Pharmacy residents sue 11 hospitals, ASHP over alleged wage fixing

A proposed class-action lawsuit accuses 11 hospitals, the American Society of Health-System Pharmacists and a matching service of attempting to suppress wages for pharmacy residents. 

Advertisement

The lawsuit, filed by two pharmacy residents Feb. 28 in the U.S. District Court for the District of Maryland, alleges that the hospitals, the ASHP and National Matching Services conspired to eliminate fair competition for pharmacy residency positions, violating federal antitrust laws, according to court documents obtained by Becker’s. 

The plaintiffs, Alexis Albert and May Ann Hudgins, filed the lawsuit on behalf of all similarly situated pharmacy residents. The complaint alleges that the hospitals used the ASHP Resident Matching Program to standardize and suppress wages, limit mobility between employers and restrict residency opportunities.

The hospitals named in the lawsuit are Johns Hopkins Hospital in Baltimore, NewYork-Presbyterian Hospital in New York City, Houston Methodist Hospital, Northwestern Memorial Hospital in Chicago, Rush University Medical Center in Chicago, University of Chicago Medical Center, Allegheny General Hospital in Pittsburgh, Hospital of the University of Pennsylvania in Philadelphia, UPMC Presbyterian Shadyside in Pittsburgh, UF Health Central Florida in Leesburg and The Queen’s Health Systems in Honolulu. 

The plaintiffs allege that the hospitals and the ASHP also conspired to exchange compensation information and control the number of residency positions available. 

The lawsuit seeks an injunction to halt the alleged antitrust practices. 

Becker’s has reached out to the ASHP for comment and will update this article if more information becomes available. 

Advertisement

Next Up in Pharmacy

  • The number of active drug shortages has declined sharply since June, according to the FDA’s drug shortage database. Seventy-five drugs…

  • From payer shifts to regulatory milestones, GLP-1 therapies for obesity and diabetes continued to reshape the healthcare landscape in December.…

  • In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval…

Advertisement

Comments are closed.